Sarah Cannon at Research Medical Center is proud to be part of the Sarah Cannon HCA Midwest Health cancer network, providing local access to innovative clinical research trials, tumor profiling and genetic counseling; you can receive top cancer care in the comfort of your community hospital.
Located in Kansas City, Research Medical Center is a Kansas City cancer center accredited by the American College of Surgeons Commission on Cancer as a Community Hospital Comprehensive Cancer Program with commendation for exceeding three national standards. Our quality measures are exceeding the national average, too.
Building on the strengths of the hospital's existing program, Sarah Cannon at Research Medical Center offers each patient a full range of screening, diagnosis, cancer treatment options and services including a state-of-the-art outpatient facility, a dedicated inpatient oncology unit and unparalleled specialized expertise.
Sarah Cannon at Research Medical Center in Kansas City is renowned for its advanced technologies and resources such as the area’s only Gamma Knife® treatment for brain tumors and the Liver and Pancreas Institute, dedicated to the treatment of cancers of the liver and biliary tract. We pride ourselves on having the most advanced technologies such as image-guided brachytherapy, linear accelerators to deliver image-guided intensity modulated radiation therapy, a 16-slice intra-operative big bore CT scanner, a 64-slice CT scanner for the clearest images to diagnose and stage tumors for treatment, and advanced cancer treatments such as Mammosite® for breast cancer.
Screenings and Self Assessments
- Low-Dose CT Scan for lung cancer screening
One exciting new advancement for gynecologic cancer patients is image-guided brachytherapy. Brachytherapy, better known as internal radiotherapy, is commonly used in the treatments of cancers of the uterus or cervix. Video features Dr. John Sheldon. Also check out the Day In The Life videos featuring many of our cancer treatment specialists.
The Cancer Programs Practice Profile Reports (CP3R) is a set of six unified measures* for breast and colorectal cancer.
The CP3R data is provided to healthcare facilities to help them:
- ensure patients are treated according to recognized standards of care,
- promote quality improvement activities to facilitate fulfillment of CoC accreditation standards, and
- accurately compare clinical performance among CoC accredited cancer programs.
Sarah Cannon at Research Medical Center is above the national rate for all six measures.
*The six measures were agreed upon by the NQF (National Quality Forum) facilitated an agreement between the CoC (Commission on Cancer), ASCO (American Society for Clinical Oncology) & NCCN (National Comprehensive Cancer Network).
Source: Commission on Cancer, National Cancer Database
|Quality Measure||Research Medical Center 2011||Missouri 2011||National 2011|
|Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with 4 or more positive regional lymph nodes||100%||84.4%||79.8%|
|Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer||100%||94.8%||92.2%|
|Tamoxifen or third generation aromatase inhibitor (hormone therapy) is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1c N0 M0 or Stage II or Stage III ERA and/or PRA positive breast cancer||97.5%||93.6%||91.1%|
For cancer-related wellness opportunities, Research Medical Center offers patients a variety of wellness services at the Center for Integrative Therapy.
Research Medical Center is an accredited facility by the American College of Surgeons.